← Open Payments lookup

GRACE FITZPATRICK: Open Payments

NPI 1245782010 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,461 in 121 payments from 20 companies in 2025. Trend: 2023 $2,471 · 2024 $2,804 · 2025 $2,461

Food & beverage: $2,384Education: $77
CompanyPaymentsAmount
ABBVIE INC.27$470
Janssen Biotech, Inc.15$410
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$227
PFIZER INC.16$197
Regeneron Healthcare Solutions, Inc.7$161
Madrigal Pharmaceuticals6$142
GENZYME CORPORATION5$136
Takeda Pharmaceuticals U.S.A., Inc.6$123
Gilead Sciences, Inc.4$97
Lilly USA, LLC3$95

Products named: TREMFYA, DUPIXENT, XIFAXAN, RINVOQ, REZDIFFRA, SKYRIZI, XELJANZ, LINZESS.

Industry payments across MD — which companies pay providers there.